Skip to main content

Advertisement

Table 1 General characteristics and the prevalence of microembolic signals of the study population (n = 40)

From: Microemboli-monitoring during the acute phase of ischemic stroke: Is it worth the time?

Prevalence of ipsilateral microemboli (95% CI) 20 (7-33)
Prevalence of contralateral micromboli (95% CI) 10 (2-20)
Prevalence of ipsilateral or contralateral microemboli (95% CI) 25 (11-39)
Mean age (SD) 70 (15.5)
Sex-male (%) 72.5
Median NIHSS (interquartile percentiles) 7 (3-12)
TIA (%) 5.1
Intracranial stenosis (%) 15
Etiology-TOAST  
Large-aretry atherosclerosis (%) 33.3
Cardioembolism (%) 28.2
Small vessel disease (%) 5.1
Other (%) 5.1
Unknown (%) 28.2
Thrombolysis (%) 61.5
Pre-existing conditions  
Stroke/TIA (%) 28.9
Atrial fibrillation (%) 16.1
Coronary artery disease (%) 15.4
Hypertension (%) 50
Diabetes mellitus (%) 10.5
Current smokers (%) 24.2
Peripheral vascular disease (%) 9.4
Migraine (%) 23.8
Depression (%) 33.3
  1. NIHSS = National Institute of Health Stroke Scale
  2. TOAST = Trial of Org 10172 in Acute Stroke Treatment
  3. TIA = Transient ischemic attack